Imelda Ko

Imelda Ko has over 8 years of consulting experience across the Life Sciences industry, serving clients including: Gilead, Baxalta, Shire, AstraZeneca, Sanofi-Aventis, Novartis and J&J subsidiaries. Imelda has advised and partnered with clients on gross to net assessments and operational best practices, gross to net forecasting/accruals/close automation solution implementations, pharmaceutical contracting/pricing/market access strategies, revenue management solution implementations (such as Model N Flex), and Government Pricing calculations via BPO support.